MedPath

Dario™ Blood Glucose Monitoring System - User Performance Evaluation

Not Applicable
Completed
Conditions
Diabetes
Interventions
Device: Dario™ Blood Glucose Meter
Device: YSI2003
Registration Number
NCT02053584
Lead Sponsor
LabStyle Innovations Ltd.
Brief Summary

The study is performed to evaluate the accuracy of blood glucose level results obtained from fingertip using Labstyle Dario Blood Glucose Monitoring System (BGMS) compared to reference equipment (YSI 2300 STATPLUS) and to evaluate the ease of use of the Dario Device by the lay-person.

The participants will review the Dario user manual and guide and will be requested to operate the Dario BGMS and perform their own glucose blood test, after which they will be asked to complete a questionnaire. As reference the participants will be tested by professional caregivers both using the Dario BGMS and by YSI 2003.

Detailed Description

Device accuracy will be assessed based on the acceptance criteria of ISO 15197:2003 which states: "The minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of Reference method at glucose concentrations ≥ 4,2 mmol/L (≥ 75 mg/dL)".

Recruitment & Eligibility

Status
COMPLETED
Sex
Not specified
Target Recruitment
230
Inclusion Criteria
  • Male or female between the age 18 and 80
  • Type 1 and Type 2 diabetes
Exclusion Criteria
  • Drug and alcohol abuse
  • Investigator discretion

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Dario BGMSDario™ Blood Glucose Meter-
Dario BGMSYSI2003-
Primary Outcome Measures
NameTimeMethod
BGMS Accuracy Assessment When Used by LaypersonWithin 6 seconds of applying blood drop to strip

The minimum acceptable accuracy for results produced by a glucose monitoring system shall be as follows: 95% of the individual glucose results shall fall within 15 mg/dL of the results of reference method (YSI) at glucose concentrations ≥ 4,2 mmol/L (≥ 75 mg/dL). (ISO 15197:2003)

Secondary Outcome Measures
NameTimeMethod
Evaluation of the Ease of Use of the Dario BGMS by the Lay-personWithin a couple of hours from the time labelling material was provided to the subject

Each participant receives a survey to fill in describing their usage of the device and their opinions on the ease of use.

© Copyright 2025. All Rights Reserved by MedPath